These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 25615)

  • 1. Physiological conditions affecting Staphylococcus aureus susceptibility to staphylococcin 1580.
    Weerkamp A; Vogels GD
    Antimicrob Agents Chemother; 1978 Feb; 13(2):146-53. PubMed ID: 25615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy requirements for the action of staphylococcin 1580 in Staphyloccus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Biochim Biophys Acta; 1978 Mar; 539(3):372-85. PubMed ID: 204362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditional killing effect of staphylococcin 1580 and repair of sublethal injury in Staphylococcus aureus.
    Weerkamp A; Geerts W; Vogels GD
    Antimicrob Agents Chemother; 1977 Sep; 12(3):314-21. PubMed ID: 20837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of staphylococcin 1580 on cells and membrane vesicles of Bacillus subtilis W23.
    Weerkamp A; Vogels GD
    Biochim Biophys Acta; 1978 Mar; 539(3):386-97. PubMed ID: 415763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and ultrastructural changes in Staphylococcus aureus treated with staphylococcin 1580.
    Weerkamp A; Heinen-von Borries UT; Vogels GD
    Antonie Van Leeuwenhoek; 1978; 44(1):35-48. PubMed ID: 655698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of staphylococcin 162: bacteriocin from Staphylococcus aureus.
    Hale EM; Hinsdill RD
    Antimicrob Agents Chemother; 1975 Jan; 7(1):74-81. PubMed ID: 1137360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD
    Antimicrob Agents Chemother; 1972 Dec; 2(6):456-63. PubMed ID: 4274969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature and properties of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD
    J Bacteriol; 1972 Oct; 112(1):243-50. PubMed ID: 5079064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid-mediated production of staphylococcin in bacteriophage type 71 Staphylococcus aureus.
    Dajani AS; Taube Z
    Antimicrob Agents Chemother; 1974 Jun; 5(6):594-8. PubMed ID: 15825411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate.
    Scott JC; Sahl HG; Carne A; Tagg JR
    FEMS Microbiol Lett; 1992 May; 72(1):97-102. PubMed ID: 1612423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and purification of a Staphylococcus epidermidis bacteriocin.
    Jetten AM; Vogels GD; de Windt F
    J Bacteriol; 1972 Oct; 112(1):235-42. PubMed ID: 5079063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity.
    Sahl HG; Brandis H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):166-75. PubMed ID: 6181629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55.
    Navaratna MA; Sahl HG; Tagg JR
    Appl Environ Microbiol; 1998 Dec; 64(12):4803-8. PubMed ID: 9835565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of colicin A and staphylococcin 1580 on amino acid uptake into membrane vesicles of Escherichia coli and staphylococcus aureus.
    Jetten AM; Vogels GD
    Biochim Biophys Acta; 1973 Jul; 311(4):483-95. PubMed ID: 4147116
    [No Abstract]   [Full Text] [Related]  

  • 15. Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria.
    Kader OA; Sahl HG; Brandis H
    J Gen Microbiol; 1984 Sep; 130(9):2291-300. PubMed ID: 6389764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of mesentericin ST99, a bacteriocin produced by Leuconostoc mesenteroides subsp. dextranicum ST99 isolated from boza.
    Todorov SD; Dicks LM
    J Ind Microbiol Biotechnol; 2004 Aug; 31(7):323-9. PubMed ID: 15252717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a Staphylococcus aureus bacteriocin.
    Gagliano VJ; Hinsdill RD
    J Bacteriol; 1970 Oct; 104(1):117-25. PubMed ID: 5473880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of staphylococcin BacR1, a broad-spectrum bacteriocin.
    Crupper SS; Gies AJ; Iandolo JJ
    Appl Environ Microbiol; 1997 Nov; 63(11):4185-90. PubMed ID: 9361402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New possibilities of staphylococcin detection in the exfoliatin-producing strains of staphylococcus aureus.
    Skalka B; Pillich J; Pospísil L
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Mar; 254(1):34-41. PubMed ID: 6675344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a bacteriocin from Staphylococcus aureus strain 462.
    Hale EM; Hinsdill RD
    Antimicrob Agents Chemother; 1973 Dec; 4(6):634-40. PubMed ID: 4793882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.